| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT07351058 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With… |
Trial sites expanded: 163 -> 193 locations |
| 2026-08-15 | NCT07239336 Study of DONQ52 in Active Celiac Disease |
Trial sites expanded: 70 -> 74 locations |
| 2026-08-15 | NCT05878769 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic… |
Enrollment closed, study ongoing |
| 2026-08-15 | NCT05878769 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic… |
Trial sites reduced: 486 -> 481 locations |
| 2026-08-15 | NCT05878769 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic… |
date change Primary completion moved earlier: 2034-07-01 -> 2027-06-30 |
| 2026-08-15 | NCT05878769 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic… |
date change Completion moved earlier: 2034-07-01 -> 2027-06-30 |
| 2026-08-15 | NCT05797610 A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants… |
Enrollment closed, study ongoing |
| 2026-08-15 | NCT05797610 A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants… |
Trial sites reduced: 204 -> 178 locations |
| 2026-08-15 | NCT07351045 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With… |
Trial sites expanded: 164 -> 195 locations |
| 2026-08-15 | NCT07158242 A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121)… |
Trial sites expanded: 15 -> 22 locations |
| 2026-08-15 | NCT04774718 A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric… |
Enrollment closed, study ongoing |
| 2026-08-15 | NCT07555938 Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in… |
Trial sites expanded: 15 -> 40 locations |
| 2026-08-15 | NCT04567303 Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration |
date change Primary completion pushed: 2026-03-10 -> 2026-08-25 |
| 2026-08-14 | NCT04603807 A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants… |
date change Primary completion moved earlier: 2028-06-26 -> 2026-09-30 |
| 2026-08-14 | NCT04603807 A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants… |
date change Completion moved earlier: 2028-06-26 -> 2028-01-29 |
| 2026-08-14 | NCT07670416 A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or… |
Trial sites expanded: 12 -> 18 locations |
| 2026-08-14 | NCT03782207 A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions… |
Trial completed |
| 2026-08-14 | NCT07667322 A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and… |
Enrollment closed, study ongoing |
| 2026-08-14 | NCT04567303 Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration |
date change Primary completion moved earlier: 2026-08-01 -> 2026-03-10 |
| 2026-08-14 | NCT05872763 A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be… |
Trial completed |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-06 | NCT07749157 A Study of Subcutaneously Administered RO7845860 in Participants With Relapsing Multiple… | Phase 1 | Not Yet Recruiting |
| 2026-08-05 | NCT07748208 A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib… | Phase 2 | Not Yet Recruiting |
| 2026-08-03 | NCT07741604 A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in… | Phase 1 | Not Yet Recruiting |
| 2026-07-21 | NCT07717411 A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05861986 | A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early… | Muscular Atrophy, Spinal | Recruiting |
| NCT06274515 | A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies | Breast Cancer | Recruiting |
| NCT04853251 | A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related… | Neovascular Age-related Macular Degeneration | Recruiting |
| NCT05861999 | A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric… | Muscular Atrophy, Spinal | Recruiting |
| NCT07609719 | A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple… | Multiple Sclerosis | Recruiting |
| NCT05224102 | A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented… | Diabetic Macular Edema | Active, Not Recruiting |
| NCT07483450 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of… | Relapsing Multiple Sclerosis | Active, Not Recruiting |
| NCT05232929 | Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA) | Spinal Muscular Atrophy | Active, Not Recruiting |
| NCT05181618 | A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants… | Severe Hemophilia A | Active, Not Recruiting |
| NCT06795048 | A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants… | Neovascular Age-related Macular Degeneration (nAMD) | Active, Not Recruiting |
| Phase 3 | |||
| NCT06675955 | An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and… | Multiple Sclerosis | Recruiting |
| NCT06094010 | A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants… | Influenza | Recruiting |
| NCT07541079 | A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant… | Early Breast Cancer | Recruiting |
| NCT06819878 | A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With… | Moderately to Severely Active Crohns Disease | Recruiting |
| NCT06847542 | A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD | Neovascular Age-related Macular Degeneration | Recruiting |
| NCT07177352 | Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's… | Alzheimers Disease | Recruiting |
| NCT05894239 | A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo… | Metastatic Breast Cancer | Recruiting |
| NCT03683251 | Extension Study for the Port Delivery System With Ranibizumab (Portal) | Neovascular Age-Related Macular Degeneration | Recruiting |
| NCT05562947 | A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System… | Neovascular Age-related Macular Degeneration | Recruiting |
| NCT06819891 | A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart… | Moderately to Severely Active Crohns Disease | Recruiting |
| NCT06065748 | A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a… | Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer | Recruiting |
| NCT06084936 | A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in… | Lymphoma | Recruiting |
| NCT06588855 | A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also… | Moderately to Severely Active Ulcerative Colitis | Recruiting |
| NCT06790693 | A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and… | Breast Cancer | Recruiting |
| NCT06793215 | A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus… | Non-Small Cell Lung Cancer | Recruiting |